Gene Query: LGR6

Dataset Description Geneva Score
EP400 is required for Max and MCPyV mediated gene activation 179.12
Controlling for gene expression changes in transcription factor protein networks. 53.73
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 43.27
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 30.15
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 29.29
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 22.33
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 21.93
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 21.93
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 21.24
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 20.9
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 20.9
Nrf2 regulated genes in A549 cells 19.25
Identification of Nrf2 regulated genes by RNA sequencing 19.25
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 18.74
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 17.93
p63 controls the enhancer landscape during keratinocyte differentiation 17.17
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 15.86
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 13.84
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 13.24
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 12.46
RIG-I and MDA5 fRIP during KSHV lytic reactivation 12.25
Gene expression profiling of leukemia cells following asparagine depletion 12.12
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 12.1
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 11.91
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 11.91
Retinoic acid suppresses MYB in adenoid cystic carcinoma 9.89
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 9.89
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 9.69
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 9.59
RNA-Seq with and without RNase treatment in PCa cell lines 8.95
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 8.76
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 8.65
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 8.5
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 7.88
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 7.72
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 7.59
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.89
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 6.87
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 6.87
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 6.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 6.74
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 6.67
6mer seed toxicity in tumour suppressive microRNAs 6.62
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 6.57
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 6.57
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 6.39
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 6.39
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 6.25
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 6.2
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 6.12
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 5.85
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 5.84
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 5.84
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 5.83
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 5.78
RNA-seq of stable and unstable section of human atherosclerotic plaques 5.62
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 5.3
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.22
Transcriptome profiling of A2M treated A549 Cell Line Samples 5.13
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.1
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 5.07
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 5.07
RNA sequencing of human pancreatic cancer cell lines 4.96
Transcriptome of activated human and mouse MAIT cells 4.81
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.8
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.8
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.47
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.36
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 4.35
RNA-seq analyisis of PUM2 knockout cells 4.2
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 4.18
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 4.09
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.97
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.97
Expression patterns in chronic thromboembolic pulmonary hypertension 3.82
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.73
RNA-Seq analysis of breast cancer cells after shikonin treatment 3.7
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.66
Crizotinib v. DMSO in SW480 cells 3.66
RNA seq comparison between scrambled and shGRP78 cells 3.55
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.46
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 3.3
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 3.25
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.91
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 2.9
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.87
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.87
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 2.87
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.85
quanTIseq: quantifying immune contexture of human tumors 2.8
Clinker: visualizing fusion genes detected in RNA-seq data 2.75
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.69
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.67
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.67
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.6
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 2.59
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 2.59
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.56
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.56
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.51
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.5
Metastasis in triple-negative breast cancer 2.47
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.47
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.44
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.4
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.39
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.38
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 2.34
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 2.34
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 2.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 2.28
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.27
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.21
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.16
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 2.16
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.14
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 2.13
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 2.13
mRNA sequencing of oropharyngeal cancer cell lines 2.12
Epigenome regulation during epidermal lineage commitment 2.12
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.12
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.12
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 2.11
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.1
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.08
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 2.05
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.04
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.02
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 1.96
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.94
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.92
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 1.89
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 1.84
Dysregulated immune system networks in war veterans with PTSD 1.84
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 1.83
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.8
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.77
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 1.72
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 1.72
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.71
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 1.66
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 1.66
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.61
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 1.6
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 1.59
Non-coding regions are the main source of tumor-specific antigens [human] 1.59
Non-coding regions are the main source of tumor-specific antigens 1.59
Transcriptomic and gene ontology profiling of the human corneal cell types 1.58
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.56
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 1.5
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.5
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.5
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.48
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 1.43
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 1.4
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.4
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.38
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.36
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.32
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.32
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.32
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.32
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.31
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.3
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.26
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 1.26
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.26
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.23
Measure transcript integrity using RNA-seq data 1.23
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.2
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.19
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.19
mRNA expression profile of Lymphocytes 1.19
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.17
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.16
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.15
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.15
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.15
RNA Sequencing of three pairs of gastric cancer 1.13
Gene expression analysis of human adenomas. 1.11
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 1.09
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.09
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.09
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.08
Transcriptional responses of melanoma cells to BRAF inhibition 1.08
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.07
circRNA profile in hypopharyngeal cancer 1.06
RNA-seq data from human lymphoma cell lines 1.06
ChIP-seq and RNA-seq from human lymphoma cell lines 1.06
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 1.04
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 1.04
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.03
HNRNPM-regulated splicing dependencies in prostate cancer 1.03
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 1.03
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 1.02
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.02
The gene expression profiles of gallbladder cancer 1.01
Transcriptional profile in human S. haematobium infection 1.0
Short and Long RNA sequencing of human mature erythrocytes 0.99
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.97
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.97
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.95
Global epigenomic reconfiguration during mammalian brain development 0.95
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.9
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.9
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.9
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.9
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.88
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 0.88
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 0.87
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.86
RNAseq analysis of ruxolitinib treated breast cancers 0.84
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 0.84
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.83
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.82
Global Mapping of Human RNA-RNA Interactions 0.82
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 0.82
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 0.81
Comparison of microRNA Profiling Platforms (HTS) 0.8
Comparison of microRNA Profiling Platforms 0.8
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.79
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.79
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.79
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.77
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.77
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 0.74
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.72
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.72
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.72
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 0.72
Multiple sclerosis and EAE 0.72
Human optic chiasm from healthy controls and multiple sclerosis patients 0.72
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 0.71
Regulation of hypoxia-inducible factor activity by ZMYND8 0.71
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.71
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.71
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.71
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.71
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.71
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 0.71
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.69
Genome-wide identification of cancer-specific alternative splicing in circRNA 0.68
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.67
Gene expression profile difference among renal location in a stone former 0.67
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.67
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 0.66
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 0.66
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.66
Transcriptome analysis of human lung epithelial cells 0.64
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.63
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.63
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.61
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.61
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.61
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.61
A prostate cancer chromatin interaction map 0.59
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.59
Gene expression changes associated with resistance to tagraxofusp (SL-401) 0.58
The Glioma-Infiltrating T Cell Receptor Repertoire 0.57
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 0.57
BAF controls genome accessibility 0.56
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.56
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.56
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.55
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 0.55
Ebola virus (EBOV) infection of ARPE-19 cells 0.55
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.55
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.54
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.54
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.53
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.53
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 0.53
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.52
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.52
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.51
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 0.51
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.49
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.49
TGF-β promotes genomic instability after loss of RUNX3 0.49
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.49
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.49
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.48
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.47
The role of the Calcium-Sensing receptor in colorectal cancer 0.47
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.46
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.46
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.46
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.46
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.46
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.46
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 0.46
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.45
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.45
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.44
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.44
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 0.44
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 0.44
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 0.44
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.43
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 0.43
Expression analysis of the TAF1 syndrome 0.43
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 0.42
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.42
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 0.42
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.42
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.41
Transcriptome analysis of CNS leukemia 0.41
Rorc disruption in human FG pancreatic cancer cells 0.41
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 0.41
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.41
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.41
Impact of dieldrin on transcription in Jurkat T cells 0.41
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 0.4
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 0.4
Identification of long noncoding RNAs regulated by p53 0.39
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.39
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.39
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.39
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 0.39
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.39
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.39
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 0.38
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 0.38
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.38
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.38
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.37
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.37
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.37
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.37
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 0.36
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 0.36
Gene expression patterns define the hepatocyte-like cells derived by different strategies 0.36
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.36
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.36
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.35
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 0.35
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.35
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.34
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.34
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 0.33
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 0.33
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.33
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.33
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 0.32
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.32
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.32
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.32
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.32
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 0.32
LncRNA expression profiling of ischemic stroke patients 0.32
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.31
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.31
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.3
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 0.3
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.29
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.29
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.28
The transcriptome and chromatin accessbility landscape of mammalian germline 0.28
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.27
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.27
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 0.27
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 0.27
BCL11B 0.27
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.26
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 0.26
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.26
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.25
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.25
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.25
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 0.25
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 0.25
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 0.25
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 0.25
Dynamic 3D chromosomal landscapes in acute leukemia 0.24
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.24
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.24
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.24
RNA-seq of SCLC PDX models treated with EP 0.24
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.23
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.23
Intron retention induced by microsatellite expansions as a disease biomarker. 0.23
Gene expression alterations of pancreatic intraepithlial neoplasia 0.22
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 0.22
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.22
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.22
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.21
mRNA-sequencing of breast cancer subtypes and normal tissue 0.21
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.2
Role of XRN2 ribonucleolytic activity in RNA metabolism 0.2
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.2
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.2
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.19
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.19
Stem and effector CD8 T-cells from human cancers 0.19
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.19
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 0.18
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 0.18
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 0.18
SRSF1 role in cellular gene expression and splicing 0.18
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.18
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.18
Hepatosplenic T cell lymphoma 0.18
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.18
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.18
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.18
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 0.17
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.17
SOX11 knockdown in B-ALL cell lines 0.17
Expression profiling of etoposide-induced senescent cells 0.17
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.17
The expression profiles of GBC liver metastasis 0.17
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 0.16
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.16
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.16
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.15
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.15
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.15
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.15
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.15
RNA-seq of naive and primed ES cells 0.15
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.15
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.15
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.15
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 0.15
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.14
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.14
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.14
Gene expression profiling in metabolically heterogeneous human lung tumors 0.14
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.14
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.14
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 0.13
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.13
Gene expression profile in breast cancer cells 0.13
Transcriptome analysis of virus infected tissues 0.13
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.13
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.12
Oncogenic roles of ARID5B in T-ALL 0.12
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.11
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.11
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.11
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.11
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.11
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.11
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.11
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.11
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.1
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.1
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.1
HEK293 Heat-shock experiment 0.09
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.09
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.09
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 0.09
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.09
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.09
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.08
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.08
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.08
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.08
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.08
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 0.08
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.08
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.07
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 0.07
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.07
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.06
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.06
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.06
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.06
The cohesin complex prevents Myc-induced replication stress 0.06
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.06
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.05
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.05
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.05
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 0.04
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 0.04
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.04
Repurposing of promoters and enhancers during mammalian evolution 0.04
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.04
Bone marrow derived human B cells [normal proB] 0.04
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.04
MHC Transcriptomic landscape at haplotype-specific resolution 0.03
Gene expression analysis in response to hypoxic pathway inhibition 0.03
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.03
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.03
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.03
RNAseq in Alzheimer's Disease patients 0.03
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.03
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.02
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.02
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.02
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.02
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 0.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 0.02
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 0.01
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.01
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.01
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.01
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation